Table 1.
Demographic and clinical characteristics of the patients
| Parameters | Non-re-positive (n = 202) | Re-positive (n = 237) | All (n = 439) | P-value |
|---|---|---|---|---|
| Sex | 0.105 | |||
| Male | 102 (50.50%) | 138 (58.23%) | 240 (54.67%) | |
| Female | 100 (49.50%) | 99 (41.77%) | 199 (45.33%) | |
| Age (years) | 41.86 ± 19.84 | 38.63 ± 19.57 | 40.09 ± 19.74 | 0.090 |
| Age group (years)a | 0.392 | |||
| 1–19 | 29 (14.87%) | 43 (18.14%) | 72 (16.67%) | |
| 20–39 | 63 (32.31%) | 87 (36.71%) | 150 (34.72%) | |
| 40–59 | 67 (34.36%) | 65 (27.43%) | 132 (30.56%) | |
| ≥60 | 36 (18.46%) | 42 (17.72%) | 78 (18.06%) | |
| Severitya | <0.001 | |||
| No symptoms | 27 (16.46%) | 0 (0.00%) | 27 (7.44%) | |
| Mild | 20 (12.20%) | 35 (17.59%) | 55 (15.15%) | |
| Moderate | 90 (54.88%) | 156 (78.39%) | 246 (67.77%) | |
| Severe and critical | 27 (16.46%) | 8 (4.02%) | 35 (9.64%) | |
| Time after symptom onset (days) | 41.66 ± 20.07 | 55.30 ± 16.57 | 49.02 ± 19.47 | <0.001 |
| Quarantine days | 4.29 ± 4.76 | 4.44 ± 4.63 | 4.38 ± 4.66 | 0.863 |
Data presented as the number and percentage, or as the mean ± standard deviation.
a
Age and disease severity data were missing for some patients, hence the sum for these two variables is not equal to the sample size of each group.